Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin’s Lymphoma: Focus on Brentuximab Vedotin

por Furtado, Michelle, Rule, Simon
Publicado 2012

A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia

por Tucker, David L, Rule, Simon A
Publicado 2015

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

por Rule, Simon A., Cartron, Guillaume, Fegan, Christopher, Morschhauser, Franck, Han, Lingling, Mitra, Siddhartha, Salles, Gilles, Dyer, Martin J. S.
Publicado 2019

Reducing Bureaucracy in Clinical Research: A Call for Action

por Gribben, John, Macintyre, Elizabeth, Sonneveld, Pieter, Doorduijn, Jeanette, Gisselbrecht, Christian, Jäger, Ulrich, Le Gouill, Steven, Rule, Simon, Dreyling, Martin
Publicado 2020

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

por Grigg, Andrew, Dyer, Martin J.S., Díaz, Marcos González, Dreyling, Martin, Rule, Simon, Lei, Guiyuan, Knapp, Andrea, Wassner-Fritsch, Elisabeth, Marlton, Paula
Publicado 2017

Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development

por Davies, Andrew, Berge, Claude, Boehnke, Axel, Dadabhoy, Anjum, Lugtenburg, Pieternella, Rule, Simon, Rummel, Mathias, McIntyre, Christine, Smith, Rodney, Badoux, Xavier
Publicado 2017

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

por Wang, Michael, Schuster, Stephen J., Phillips, Tycel, Lossos, Izidore S., Goy, Andre, Rule, Simon, Hamadani, Mehdi, Ghosh, Nilanjan, Reeder, Craig B., Barnett, Evelyn, Bravo, Marie-Laure Casadebaig, Martin, Peter
Publicado 2017

Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study

por Strati, Paolo, de Vos, Sven, Ruan, Jia, Maddocks, Kami J., Flowers, Christopher R., Rule, Simon, Patel, Priti, Xu, Yan, Wei, Helen, Frigault, Melanie M., Calvo, Roser, Dyer, Martin J.S.
Publicado 2021

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.

por Le Gouill, Steven, Morschhauser, Franck, Chiron, David, Bouabdallah, Kamal, Cartron, Guillaume, Olivier Casasnovas, Rene, Milin, Caroline, Herbaux, Charles, Tchernonog, Emmanuelle, Rossi, Cedric, Rule, Simon, Gastinne, Thomas, Callanan, Mary, Tessoulin, Benoit
Publicado 2023

ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for...

por Davies, Andrew, Barrans, Sharon, Burton, Cathy, Mercer, Katy, Caddy, Joshua, Chinnery, Fay, Day, Laura, Fernando, Diana, Ardeshna, Kirit, Collins, Graham, Radford, John, Rule, Simon, McMillan, Andrew, Johnson, Peter, Griffiths, Gareth
Publicado 2020

Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III...

por Rule, Simon, Barreto, Wolney Gois, Briones, Javier, Carella, Angelo M., Casasnovas, Olivier, Pocock, Chris, Wendtner, Clemens-Martin, Zaja, Francesco, Robson, Susan, MacGregor, Lachlan, Tschopp, Roger R., Nick, Sonja, Dreyling, Martin
Publicado 2021

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial

por Phillips, Elizabeth H., Burton, Catherine, Kirkwood, Amy A., Barrans, Sharon, Lawrie, Anthony, Rule, Simon, Patmore, Russell, Pettengell, Ruth, Ardeshna, Kirit M., Montoto, Silvia, Paneesha, Shankara, Clifton‐Hadley, Laura, Linch, David C., McMillan, Andrew K.
Publicado 2020

Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma

por Arcaini, Luca, Lamy, Thierry, Walewski, Jan, Belada, David, Mayer, Jiri, Radford, John, Jurczak, Wojciech, Morschhauser, Franck, Alexeeva, Julia, Rule, Simon, Cabeçadas, José, Campo, Elias, Pileri, Stefano A., Biyukov, Tsvetan, Patturajan, Meera, Casadebaig Bravo, Marie‐Laure, Trnĕný, Marek
Publicado 2017

Is Good Clinical Practice Becoming Poor Clinical Care?

por Le Gouill, Steven, Dreyling, Martin, Caballero, Maria Dolores, Andre, Marc, Doorduijn, Jeannette, Jurczak, Wojciech, Jerkeman, Mats, Ghia, Paolo, Zinzani, Pier-Luigi, Da Silva, Maria Gomez, Dimopoulos, Meletios, Trneny, Marek, Delarue, Richard, Walewski, Jan, Gisselbrecht, Christian, López-Guillermo, Armando, Rule, Simon
Publicado 2017

Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial

por Casulo, Carla, Santoro, Armando, Cartron, Guillaume, Ando, Kiyoshi, Munoz, Javier, Le Gouill, Steven, Izutsu, Koji, Rule, Simon, Lugtenburg, Pieternella, Ruan, Jia, Arcaini, Luca, Casadebaig, Marie‐Laure, Fox, Brian, Kilavuz, Nurgul, Rettby, Nils, Dell'Aringa, Justine, Taningco, Lilia, Delarue, Richard, Czuczman, Myron, Witzig, Thomas
Publicado 2022

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

por Morschhauser, Franck, Dyer, Martin J. S., Walter, Harriet S., Danilov, Alexey V., Ysebaert, Loic, Hodson, Daniel James, Fegan, Christopher, Rule, Simon A., Radford, John, Cartron, Guillaume, Bouabdallah, Krimo, Davies, Andrew John, Spurgeon, Stephen, Rajakumaraswamy, Nishanthan, Li, Biao, Humeniuk, Rita, Huang, Xi, Bhargava, Pankaj, Jürgensmeier, Juliane M., Salles, Gilles
Publicado 2020

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic...

por Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela, Cramer, Paula
Publicado 2020

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials

por Brown, Jennifer R., Moslehi, Javid, O’Brien, Susan, Ghia, Paolo, Hillmen, Peter, Cymbalista, Florence, Shanafelt, Tait D., Fraser, Graeme, Rule, Simon, Kipps, Thomas J., Coutre, Steven, Dilhuydy, Marie-Sarah, Cramer, Paula, Tedeschi, Alessandra, Jaeger, Ulrich, Dreyling, Martin, Byrd, John C., Howes, Angela, Todd, Michael, Vermeulen, Jessica, James, Danelle F., Clow, Fong, Styles, Lori, Valentino, Rudy, Wildgust, Mark, Mahler, Michelle, Burger, Jan A.
Publicado 2017

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis

por Brown, Jennifer R., Moslehi, Javid, Ewer, Michael S., O'Brien, Susan M., Ghia, Paolo, Cymbalista, Florence, Shanafelt, Tait D., Fraser, Graeme, Rule, Simon, Coutre, Steven E., Dilhuydy, Marie‐Sarah, Cramer, Paula, Jaeger, Ulrich, Dreyling, Martin, Byrd, John C., Treon, Steven, Liu, Emily Y., Chang, Stephen, Bista, Amulya, Vempati, Rama, Boornazian, Lisa, Valentino, Rudolph, Reddy, Vijay, Mahler, Michelle, Yang, Huiying, Graef, Thorsten, Burger, Jan A.
Publicado 2018

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

por Bewicke-Copley, Findlay, Korfi, Koorosh, Araf, Shamzah, Hodkinson, Brendan, Kumar, Emil, Cummin, Thomas, Ashton-Key, Margaret, Barrans, Sharon, van Hoppe, Suzan, Burton, Cathy, Elshiekh, Mohamed, Rule, Simon, Crosbie, Nicola, Clear, Andrew, Calaminici, Maria, Runge, Hendrik, Hills, Robert K., Scott, David W., Rimsza, Lisa M., Menon, Geetha, Sha, Chulin, Davies, John R., Nagano, Ai, Davies, Andrew, Painter, Daniel, Smith, Alexandra, Gribben, John, Naresh, Kikkeri N., Westhead, David R., Okosun, Jessica, Steele, Andrew, Hodson, Daniel J., Balasubramanian, Sriram, Johnson, Peter, Wang, Jun, Fitzgibbon, Jude
Publicado 2022